Collaboration: GS1 and Joint Initiative Council (JIC) in Healthcare

Size: px
Start display at page:

Download "Collaboration: GS1 and Joint Initiative Council (JIC) in Healthcare"

Transcription

1 Collaboration: GS1 and Joint Initiative Council (JIC) in Healthcare International Organisation for Standardization European Committee for Standardization Health Level 7 international International Health Terminology SDO Clinical Data Interchange Standards Consortium Integrating the Healthcare Enterprise World Health Organization World Customs Organization International Society for Blood Transfusion European Association of Hospital Pharmacists European Association of Medical Device manufacturer European Association of Pharmaceutical Manufacturer 1

2 Regulations in Healthcare Unique Device Identification: GS1accredited as UDI Issuing Agency by U.S. Food & Drug Administration (FDA) And other UDI regulations under development wordlwide Importance of Asian Harmonisation Working Party Regulatory bodies mandating traceability to fight against falsified medicines 2

3 UDI Purpose A common, worldwide system for product identification should eliminate differences between jurisdictions and offer significant benefits to manufacturers, users and/or patients, and regulatory authorities. 3

4 Unique Device Identification 1. A standardized system to develop Unique Device Identification numbers (UDI) 2. UDI in human readable and bar code/rfid on the device label 3. Data to be submitted to the UDI Database 4. Users need to implement. FDA expects GS1 to play a major role. 4

5 Examples of GS1 current activities in Asia-Pacific Facilitating the Track and Trace Systems Working Group of APEC project on Global Medical Product Integrity and Supply Chain Security: Strategic Roadmap and training Tool Kits to be developed Cooperating with regulatory bodies and with key trade associations on globally harmonised implementation of UDI systems: work with IMDRF members, supporting the US FDA on UDI regulations as UDI issuing agency, participation in key events and meetings with regional regulatory authorities GS1 Global Healthcare conferences: non-for-profit conferences bringing together regulators, industry and hospitals to learn from the latest updates and experiences directly from their local and international colleagues from over 25 countries Latest conference: 1-3 April 2014, Seoul, South Korea 5

6 Asian Harmonization Working Party Goals - To study and recommend ways to harmonize MD regulations in the Asian and other regions establish harmonized requirements, procedures and standards to coordinate with the GHTF/IMDRF, APEC and other related GS1 appointed as liaison member of the AHWP in December 2013, providing technical expertise 6

7 New McKinsey & Company report quantifies supply chain issues in Healthcare New McKinsey report Strength in unity: The promise of global standards in healthcare Highlights the cost savings and patient safety benefits of adopting a single global supply chain standard in healthcare Source: Available at: 7

8 Huge patient safety benefits and cost savings when adopting a single global standard in healthcare Implementing global standards across the entire healthcare supply chain could save 22,000-43,000 lives and avert 0.7 million to 1.4 million patient disabilities Rolling out such standards-based systems globally could prevent tens of billions of dollars worth of counterfeit drugs from entering the legitimate supply chain [We] estimate that healthcare cost could be reduced by $40 billion-$100 billion globally from the implementation of global standards Adopting a single set of global standards will cost significantly less than two (between 10-25% less cost to stakeholders) SOURCE: McKinsey report, Strength in unity: The promise of global standards in healthcare, October

9 55 Healthcare Leaders endorse GS1 Standards 9

10 Imagine a world where bedside scanning confirms that the patient gets the right product in the right dosage at the right time and the patient records captures all the details. where hospitals and pharmacies know the exact location of short-supply medical devices and drugs and when they can be delivered. where regulators can recall products with accuracy and speed from every point in the supply chain and there is no possibility of receiving a counterfeit product. 10

11 THANK YOU VERY MUCH!!!! 11

Where and how to start implementing GS1 standards in a hospital

Where and how to start implementing GS1 standards in a hospital Where and how to start implementing GS1 standards in a hospital Tania Snioch, GS1 Global Feargal Mc Groarty, National Centre for Hereditary Coagulation Disorders, St James s Hospital, Ireland WHY? GS1

More information

The healthcare stakeholders expressed their strong support in the adoption of GS1 as the global standard best suited for their industry

The healthcare stakeholders expressed their strong support in the adoption of GS1 as the global standard best suited for their industry The healthcare stakeholders expressed their strong support in the adoption of GS1 as the global standard best suited for their industry Implementing global standards across the entire healthcare supply

More information

Welcome to our 29 th Global GS1 Healthcare Conference. Follow us on Twitter and tweet about the #GS1HCuae

Welcome to our 29 th Global GS1 Healthcare Conference. Follow us on Twitter and tweet about the #GS1HCuae Welcome to our 29 th Global GS1 Healthcare Conference Follow us on Twitter and tweet about the conference! @GS1Healthcare #GS1HCuae Welcome to the conference 29 th Global GS1 Healthcare Conference Dubai,

More information

GS1 Healthcare Newsletter

GS1 Healthcare Newsletter No. 25 Q4 2012 table of contents Special feature: GS1 Healthcare Conference Gathers in Lisbon 1 GS1 Healthcare takes the stage in Lisbon 1 McKinsey & Company reports on the benefits a single global standard

More information

The world of GS1 standards in healthcare. Chris Adcock GS1 Global Office

The world of GS1 standards in healthcare. Chris Adcock GS1 Global Office The world of GS1 standards in healthcare Chris Adcock GS1 Global Office Topics Background Where we are going Where we are today What this means to you Questions Background Topics Where we are going Where

More information

GS1 Ireland Healthcare User Group (HUG) Information Day

GS1 Ireland Healthcare User Group (HUG) Information Day GS1 Ireland Healthcare User Group (HUG) Information Day Overview on EU FMD regulation and unique identification requirements Geraldine Lissalde-Bonnet, GS1 Global Office 28 th March 2017 Overview on EU

More information

Health Care/Pharmaceutical. GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain

Health Care/Pharmaceutical. GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain 1 Health Care/Pharmaceutical GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain 2 Health Care/Pharmaceutical: GS1 Standards for Serialization and Visibility Within

More information

GS1 Guide on Unique Device Identification (UDI) implementation

GS1 Guide on Unique Device Identification (UDI) implementation GS1 Guide on Unique Device Identification (UDI) implementation This document aims at providing clarification to questions raised by the industry as well as implementation guidance on the use of GS1 standards.

More information

GS1 Healthcare 2018 Strategic Priorities. January 2018

GS1 Healthcare 2018 Strategic Priorities. January 2018 GS1 Healthcare 2018 Strategic Priorities January 2018 GS1 Healthcare 2018 Strategic Priorities Vision: To be the recognised, open and neutral source for regulatory agencies, trade organisations and other

More information

B.Braun: Global Regulatory Compliance Achieves Additional Benefits

B.Braun: Global Regulatory Compliance Achieves Additional Benefits TM CASE STUDY B.Braun: Global Regulatory Compliance Achieves Additional Benefits Challenge The healthcare landscape is experiencing a significant transformation. Today s patients are savvy consumers, demanding

More information

Global Medical Device Nomenclature: The Concept for Reducing Device-Related Medical Errors

Global Medical Device Nomenclature: The Concept for Reducing Device-Related Medical Errors Quality Assurance Global Medical Device Nomenclature: The Concept for Reducing Device-Related Medical Errors Anand K, Saini SK 1, Singh BK 2, Veermaram C Department of Pharmaceutics, Faculty of Pharmaceutical

More information

Membership Registration Form. Company Details

Membership Registration Form. Company Details Membership Registration Form This form allows you to become a voting or non-voting member of GS1 Healthcare, the global healthcare user group. GS1 Healthcare welcomes the following stakeholders as voting

More information

CYTOTOXIC TRACEABILITY AND PATIENT WRISTBANDS

CYTOTOXIC TRACEABILITY AND PATIENT WRISTBANDS CYTOTOXIC TRACEABILITY AND PATIENT WRISTBANDS Pr Pascal BONNABRY Head of pharmacy Global GS1 Healthcare Conference Dubai, April 18, 2016 Introduction A full traceability of the medication process is the

More information

GS1 Healthcare - Discussion paper on multi-market packs for pharmaceutical products

GS1 Healthcare - Discussion paper on multi-market packs for pharmaceutical products Purpose This GS1 Healthcare paper has been written to help demonstrate ways in which GS1 bar codes can be used to minimise the need for multiple bar codes to appear on product packaging while still enabling

More information

Verification of Pharmaceutical Products at the Point of Dispense. An EFPIA update

Verification of Pharmaceutical Products at the Point of Dispense. An EFPIA update Verification of Pharmaceutical Products at the Point of Dispense Speaker : Grant Courtney Event: GS1 Global Conference Location: Washington An EFPIA update 1 Who is EFPIA? The European Federation of Pharmaceutical

More information

Appropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products

Appropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products Date: April 23, 2012 Appropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products Key Messages Importation quality control testing for pharmaceutical, biological/biotechnology

More information

MDSAP Me M dical D e D vice S i S ngle Audit Program

MDSAP Me M dical D e D vice S i S ngle Audit Program MDSAP Medical Device Single Audit Program Gary Minks VP, Quality & Regulatory Affairs TÜV SÜD America Inc. gminks@tuvam.com Revision: 2013(09(29 TÜV SÜD America 13(04(29 Slide 1 IMDRF International Medical

More information

Healthcare Technology Assessment Division HTAD of the International Federation for Medical and Biological Engineering IFMBE

Healthcare Technology Assessment Division HTAD of the International Federation for Medical and Biological Engineering IFMBE Healthcare Technology Assessment Division HTAD of the International Federation for Medical and Biological Engineering IFMBE Nicolas Pallikarakis University of Patras, Greece Chairman of HTAD Second WHO

More information

Mass Serialization and Traceability Implementation in the Pharma Industry. Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland

Mass Serialization and Traceability Implementation in the Pharma Industry. Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland Mass Serialization and Traceability Implementation in the Pharma Industry Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland What drives the industry towards more traceability Strategic

More information

Healthcare GTIN Allocation Rules

Healthcare GTIN Allocation Rules Healthcare GTIN Allocation Rules GS1 Global Healthcare User Group 03 October 2007, Final All contents copyright GS1 2007 Page 1 of 25 Document Summary Document Item Document Title Current Value Healthcare

More information

GS1 Turkey Yeliz Geriş. İTS -Turkish Pharmaceutical Track and Trace System

GS1 Turkey Yeliz Geriş. İTS -Turkish Pharmaceutical Track and Trace System GS1 Turkey Yeliz Geriş İTS -Turkish Pharmaceutical Track and Trace System What is İTS? İTS-Pharmaceutical Track & Trace System Project Phases Implementation Timeline Objectives Scope Labeling Workflow

More information

Oktober 4, 2011 Els C.M. van der Wilden-van Lier, MD, MPH Board of Governors / CMO ZGT. GS1 in Dutch Hospitals

Oktober 4, 2011 Els C.M. van der Wilden-van Lier, MD, MPH Board of Governors / CMO ZGT. GS1 in Dutch Hospitals Oktober 4, 2011 Els C.M. van der Wilden-van Lier, MD, MPH Board of Governors / CMO ZGT GS1 in Dutch Hospitals Overview ZGT in figures and key issues Healthcare 2011 Challenge Barcode Lessons learned in

More information

Data as the key understanding all the options for business improvement Panel

Data as the key understanding all the options for business improvement Panel Data as the key understanding all the options for business improvement Panel Mark Brommeyer, Manager Supply Chain, NEHTA Richard Bowen, Manager Data Systems and Reporting, HPV Steve Capel, Director Global

More information

Drug Supply Chain Security Act Implementation Track and Trace Issues in 2017

Drug Supply Chain Security Act Implementation Track and Trace Issues in 2017 Drug Supply Chain Security Act Implementation Track and Trace Issues in 2017 ILISA BG BERNSTEIN, PharmD, JD Deputy Director, Office of Compliance FDA/CDER Presented at: FDLI DQSA Conference November 15,

More information

Mr. Mesay Menebo Dr. Bjorn Jaeger (Associate professor)

Mr. Mesay Menebo Dr. Bjorn Jaeger (Associate professor) Mitigating supply chain challenges through the application of a new, sequential assessment tool - MIAAF developed based on a case study of a pharmaceutical supply chain. Mr. Mesay Menebo Dr. Bjorn Jaeger

More information

Section I: Pharmaceuticals and Medical Devices

Section I: Pharmaceuticals and Medical Devices SUPPLEMENT on HEALTHCARE INNOVATION Visionary Goals and Recommendations 51th Japan-U.S. Business Conference Japan-U.S. Business Council / U.S.-Japan Business Council November 14, 2014 The R&D-based pharmaceutical

More information

SE09. Track & Trace Solutions Jeff Bredemus Werner Electric

SE09. Track & Trace Solutions Jeff Bredemus Werner Electric SE09 Track & Trace Solutions Jeff Bredemus Werner Electric Related Topics SE02 Balluff RFID SE03 Benefits of Image Based Barcode Reading SE08 Vision Solutions for the Food Ind. Solution Area 5 (Motion

More information

Indian medicine manufacturer Medreich PLC improves production and quality with coding solutions from Videojet

Indian medicine manufacturer Medreich PLC improves production and quality with coding solutions from Videojet Thermal Inkjet Medreich PLC Case Study Indian medicine manufacturer Medreich PLC improves production and quality with coding solutions from Videojet Medreich PLC is a fully integrated pharmaceutical company

More information

Pharmaceutical RFID: From Mandates to Endorsements and Laws

Pharmaceutical RFID: From Mandates to Endorsements and Laws Pharmaceutical RFID: From Mandates to Endorsements and Laws By Sara Shah, Industry Analyst, RFID and M2M Research, ABI Research The healthcare industry s motivation for adopting RFID can be attributed

More information

HEALTHCARE. > Healthcare is moving forward

HEALTHCARE. > Healthcare is moving forward HEALTHCARE > Healthcare is moving forward Technology for Healthcare, The Healthcare Industry In healthcare it is critical to provide the most advanced patient safety, excellent care, and efficient communication

More information

Establishment of Clinical Trial Infrastructure

Establishment of Clinical Trial Infrastructure Taiwan s Strategy in the Establishment of Clinical Trial Infrastructure Chei-Hsiang Chen, Ph. D. Director, Biotechnology and Pharmaceutical Industries Program Office, Ministry of Economic Affairs, Taiwan

More information

US FDA and International Regulatory Efforts in Cellular and Gene Therapies

US FDA and International Regulatory Efforts in Cellular and Gene Therapies US FDA and International Regulatory Efforts in Cellular and Gene Therapies ISCT Satellite Global Regulatory Perspectives Workshop January 27, 2013 Kimberly Benton, Ph.D. Deputy Director, Division of Cellular

More information

Labeling Best Practice in a Challenging Manufacturing Landscape A survival guide for pharmaceutical companies

Labeling Best Practice in a Challenging Manufacturing Landscape A survival guide for pharmaceutical companies Labeling Best Practice in a Challenging Manufacturing Landscape A survival guide for pharmaceutical companies White Paper www.nicelabel.com/pharma 1 1 Executive summary The number of challenges for the

More information

NEW YORK STATE BAR ASSOCIATION FOOD, DRUG AND COSMETIC LAW SECTION AND HEALTH LAW SECTION COMMITTEE ON MEDICAL RESEARCH AND BIOTECHNOLOGY

NEW YORK STATE BAR ASSOCIATION FOOD, DRUG AND COSMETIC LAW SECTION AND HEALTH LAW SECTION COMMITTEE ON MEDICAL RESEARCH AND BIOTECHNOLOGY NEW YORK STATE BAR ASSOCIATION FOOD, DRUG AND COSMETIC LAW SECTION AND HEALTH LAW SECTION COMMITTEE ON MEDICAL RESEARCH AND BIOTECHNOLOGY MEMORANDUM IN SUPPORT OF AN AMENDMENT TO NEW YORK S PHARMACY LAW

More information

Paul Ashford Executive Director ICCBBA

Paul Ashford Executive Director ICCBBA Introduction to ISBT 128 Paul Ashford Executive Director ICCBBA ICCBBA ICCBBA enhances safety for patients by managing the ISBT 128 international information standard for use in transfusion and transplantation.

More information

DITTA CONTRIBUTION TO IMDRF STAKEHOLDER FORUM

DITTA CONTRIBUTION TO IMDRF STAKEHOLDER FORUM DITTA CONTRIBUTION TO IMDRF STAKEHOLDER FORUM Satoshi Kimura DITTA Chair JIRA Executive Director IMDRF Stakeholder Forum Tokyo, 25 Mar. 2015 Key Topics Updates about DITTA DITTA views on current work items

More information

Impact of WHO Guidelines on GMP for Blood Establishments

Impact of WHO Guidelines on GMP for Blood Establishments Impact of WHO Guidelines on GMP for Blood Establishments Christian Schärer, Ph.D. Swissmedic, Swiss Agency for Therapeutic Products, Head Inspectorate International Conference of Drug Regulatory Authorities

More information

Mandate and objectives for the EMA Working Party on Quality Review of Documents (QRD)

Mandate and objectives for the EMA Working Party on Quality Review of Documents (QRD) 1 July 2014 EMA/403106/2014 Mandate and objectives for the EMA Working Party on Quality Review of Documents 1. General considerations The European Medicines Agency (EMA) created an ad hoc Working Group

More information

Taking a Leap Toward Global Supply Chain Efficiency - Part II

Taking a Leap Toward Global Supply Chain Efficiency - Part II Taking a Leap Toward Global Supply Chain Efficiency - Part II 2 Supply Chain Brochure - Part II INTRODUCTION Pharmaceutical manufacturers face a number of challenges in the production and delivery of medicinal

More information

Solving Healthcare Challenges. Increasing patient safety, reducing errors and improving efficiencies with Intermec Healthcare Solutions.

Solving Healthcare Challenges. Increasing patient safety, reducing errors and improving efficiencies with Intermec Healthcare Solutions. Solving Healthcare Challenges Increasing patient safety, reducing errors and improving efficiencies with Intermec Healthcare Solutions. You re under unprecedented pressure. As a healthcare provider, you

More information

End-to-End Management of Clinical Trials Data

End-to-End Management of Clinical Trials Data End-to-End Management of Clinical Trials Data A Revolutionary Step Toward Supporting Clinical Trials Analysis Over the Next Decades of Clinical Research WHITE PAPER SAS White Paper Table of Contents Introduction....

More information

Charter on Access to Health in Developing Countries

Charter on Access to Health in Developing Countries Charter on Access to Health in Developing Countries Fake Medicines July 2014 Our Promise Merck is a leading company for innovative and top-quality high-tech products. As the oldest pharmaceutical and chemical

More information

CTS East Coast. Increasing Agility and Innovation in the Clinical Supply Chain for Cost Optimization. Connect with us to connect with Asia

CTS East Coast. Increasing Agility and Innovation in the Clinical Supply Chain for Cost Optimization. Connect with us to connect with Asia Increasing Agility and Innovation in the Clinical Supply Chain for Cost Optimization Connect with us to connect with Asia CTS East Coast Oct 19 th, 2011 Philadelphia Introduction Zuellig Pharma Asia Pacific

More information

MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155

MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155 MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155 EXECUTIVE SUMMARY Medical device regulations around the world generally require manufacturers of most types of medical devices to supply data as part

More information

Updated EU Medical Device Regula2ons: What s In, What s Out, and What s Hot?

Updated EU Medical Device Regula2ons: What s In, What s Out, and What s Hot? Updated EU Medical Device Regula2ons: What s In, What s Out, and What s Hot? Introduc2on EU Medical Device Overview Current Medical Device Direc2ves ü Governed by 3 directives (past 15-20 yrs): Polling

More information

The use of electronic Health Records in Clinical Research - The value of CDISC Standards

The use of electronic Health Records in Clinical Research - The value of CDISC Standards The use of electronic Health Records in Clinical Research - The value of CDISC Standards FH-Prof. Dr. Jozef Aerts University of Applied Sciences FH Joanneum Graz, Austria Who is Jozef Aerts? CDISC volunteer

More information

Using local RWD to drive global therapeutic advancements.

Using local RWD to drive global therapeutic advancements. Using local RWD to drive global therapeutic advancements. Helsinki, 30 th Nov 2016 Mike Spencer, Head of Real World Evidence, EMEA, Janssen The following represent my own views and not necessarily those

More information

Regulatory system strengthening

Regulatory system strengthening SIXTY-SEVENTH WORLD HEALTH ASSEMBLY A67/32 Provisional agenda item 15.6 14 March 2014 Regulatory system strengthening Report by the Secretariat 1. The Executive Board at its 134th session noted an earlier

More information

E2B(R3): THE INSIDE SCOOP FOR PRODUCT SAFETY TEAMS IN LIFE SCIENCES

E2B(R3): THE INSIDE SCOOP FOR PRODUCT SAFETY TEAMS IN LIFE SCIENCES E2B(R3): THE INSIDE SCOOP FOR PRODUCT SAFETY TEAMS IN LIFE SCIENCES PREPARING FOR E2B(R3) T he electronic transmission of adverse event information to stakeholders, using the International Conference on

More information

WHITE PAPER. Solutions to Global Pharmaceutical Supply Chain Challenges

WHITE PAPER. Solutions to Global Pharmaceutical Supply Chain Challenges WHITE PAPER Solutions to Global Pharmaceutical Supply Chain Challenges Solutions to Global Pharmaceutical Supply Chain Challenges Find out how a contract packaging company can deliver the expertise and

More information

IHE Pharmacy Technical Framework Supplement. Uniform Barcode Processing (UBP) Rev. 1.0 Draft for Public Comment

IHE Pharmacy Technical Framework Supplement. Uniform Barcode Processing (UBP) Rev. 1.0 Draft for Public Comment Integrating the Healthcare Enterprise 5 IHE Pharmacy Technical Framework Supplement 10 Uniform Barcode Processing (UBP) 15 HL7 FHIR STU 3 Using Resources at FMM Level 2-5 Rev. 1.0 Draft for Public Comment

More information

University Health Network UDI Capture Work Group Case Study

University Health Network UDI Capture Work Group Case Study LEARNING UDI COMMUNITY University Health Network UDI Capture Work Group Case Study WWW.AHRMM.ORG / LUC WORK GROUP TITLE: UDI Capture Work Group CASE STUDY PARTICIPANTS Wendy Watson, OR Supply Chain Manager

More information

Pharmamarketing - strategic challenges

Pharmamarketing - strategic challenges Pharmamarketing - strategic challenges Biomedicine Master Program Lund University Course: Biomedicine the Profession Anna Chérouvrier Hansson, MSc. December 16th, 2014 1. Pharmamarketing - definitions

More information

DRUG WHOLESALING AND IMPORTATION: CHALLENGES. AND OPPORTUNITIESt. Giacalone,: Drug Wholesaling and Importation: Challenges and Opportunities

DRUG WHOLESALING AND IMPORTATION: CHALLENGES. AND OPPORTUNITIESt. Giacalone,: Drug Wholesaling and Importation: Challenges and Opportunities Giacalone,: Drug Wholesaling and Importation: Challenges and Opportunities DRUG WHOLESALING AND IMPORTATION: CHALLENGES AND OPPORTUNITIESt ROBERT P. GIACALONE, R.PH., J.D.* ABSTRACT Much interest and controversy

More information

Healthcare. Frequently Asked Questions (FAQs) by the Pharmaceutical Industry in Preparing for the U.S. DSCSA

Healthcare. Frequently Asked Questions (FAQs) by the Pharmaceutical Industry in Preparing for the U.S. DSCSA Healthcare Frequently Asked Questions (FAQs) by the Pharmaceutical Industry in Preparing for the U.S. DSCSA Release 1.0, May 23 2017 Table of Contents 1 Introduction... 7 2 IDENTIFY: Questions about GS1

More information

Saudi FDA Drug Approval Process. Dr. Mohammed A. Alquwaizani Consultant- Chief of the scientific office Saudi Food and Drug Authority

Saudi FDA Drug Approval Process. Dr. Mohammed A. Alquwaizani Consultant- Chief of the scientific office Saudi Food and Drug Authority Saudi FDA Drug Approval Process Dr. Mohammed A. Alquwaizani Consultant- Chief of the scientific office Saudi Food and Drug Authority Objective Describe the drug regulation practice in Saudi Arabia and

More information

Perfect Order and Beyond

Perfect Order and Beyond SMI Fall Forum 5/17/12 Curtis Dudley, ROi, Vice President of Integrated Business Solutions Dennis Black, BD, Director, e-business BD FORTUNE 500 company (#316) Locations in more than 50 countries Approximately

More information

Dr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority

Dr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority CHALLENGES AND OPPORTUNITIES IN COLD CHAIN: HEALTH CARE RELATED DRIVERS Dr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority AGENDA Integrating stakeholders

More information

EU Orphan Drug Launch

EU Orphan Drug Launch EU Orphan Drug Launch Understanding and delivering your EU Orphan Drug Launch Almac Pharma Services EU Orphan Drug Launch Find out more at our website ebook contents Share me Section 1 The EU rare disease

More information

An industry perspective on medicines barcoding and bedside scanning

An industry perspective on medicines barcoding and bedside scanning An industry perspective on medicines barcoding and bedside scanning Chris Dierickx Manager Business Development - Pfizer Global Supply Puurs Monday the 14 th of October 2013 Content Introduction Pfizer

More information

LUC UOU Examples Talk Track

LUC UOU Examples Talk Track LUC UOU Examples Talk Track (Slide 1): Welcome to the AHRMM Learning UDI Community. This presentation is intended to provide more information on potential use cases for the Unit of Use (also known as the

More information

The Belgian pharmaceutical industry strengthens its leading European position. Belgian pharma figures 2015, in a European perspective

The Belgian pharmaceutical industry strengthens its leading European position. Belgian pharma figures 2015, in a European perspective The Belgian pharmaceutical industry strengthens its leading European position Belgian pharma figures 2015, in a European perspective INTRODUCTION In 2015, Belgium continued to reinforce its leading position

More information

Brand Protection: In the face of mounting counterfeiting, diversion & other infringements. Jim Mentone Director, Consumer Global Brand Protection

Brand Protection: In the face of mounting counterfeiting, diversion & other infringements. Jim Mentone Director, Consumer Global Brand Protection Brand Protection: In the face of mounting counterfeiting, diversion & other infringements Jim Mentone Director, Consumer Global Brand Protection Objective: Create active collaboration group MFGs & Retailers:

More information

Niccolo Machiavelli (1523)

Niccolo Machiavelli (1523) Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those

More information

Healthcare & Lifesciences Whitepaper

Healthcare & Lifesciences Whitepaper Healthcare & Lifesciences Whitepaper 1 Introduction Healthcare and Life Sciences (HLS) organizations are committed towards enhancing the lives and well-being of people around the world. They have not been

More information

In the huge expanse of Asia, Singapore and

In the huge expanse of Asia, Singapore and New Medical Device Regulation 16 February 2009 By Ames Gross In the huge expanse of Asia, Singapore and Hong Kong are small places. However, after Japan, they are among the most advanced medical markets

More information

Digitally Connected RAIN Embedded Solutions for IoT Eric Wood, VP Product Management, Printed Electronics

Digitally Connected RAIN Embedded Solutions for IoT Eric Wood, VP Product Management, Printed Electronics Digitally Connected RAIN Embedded Solutions for IoT Eric Wood, VP Product Management, Printed Electronics That s quite a mouthful what does it mean? Digitally Connected Information is available when needed

More information

The interface between Good Clinical Practice and Good Manufacturing Practice

The interface between Good Clinical Practice and Good Manufacturing Practice 1 The interface between Good Clinical Practice and Good Manufacturing Practice your partner in compliance 1 The interface between GCP and GMP Generally, studies are designed and planned by physicians who

More information

Medical Device Single Audit Program (MDSAP)

Medical Device Single Audit Program (MDSAP) Medical Device Single Audit Program (MDSAP) Paul Brooks Senior Vice President BSI Healthcare Solutions Copyright 2015 BSI. All rights reserved. 1 Agenda What is MDSAP? How does MDSAP work? I already have

More information

Biosimilar regulation in Republic of Korea and Asia-Pacific Economic Cooperation (APEC) developments

Biosimilar regulation in Republic of Korea and Asia-Pacific Economic Cooperation (APEC) developments Biosimilar regulation in Republic of Korea and Asia-Pacific Economic Cooperation (APEC) developments Ministry of Food and Drug Safety Jeewon Joung Outline I. Korean Regulatory Framework for Biosimilar

More information

IMPLEMENTATION REALITY SESSION Unique Device Identification (UDI)

IMPLEMENTATION REALITY SESSION Unique Device Identification (UDI) IMPLEMENTATION REALITY SESSION Unique Device Identification (UDI) Introductory Session AIDC & GDSN GS1 Healthcare Conference Mexico City 22 April 2015 UDI Implementation Reality Our Panel GS1 AIDC UDI

More information

Provided by TryEngineering - Click here to provide feedback on this lesson.

Provided by TryEngineering -  Click here to provide feedback on this lesson. Provided by TryEngineering - Click here to provide feedback on this lesson. Lesson Focus Lesson focuses on how computerized barcodes have improved efficiency in product distribution; explores the barcoding

More information

PROPOSED DOCUMENT. Playbook for Implementation of a Medical Device Regulatory Framework. Authoring Group: AHWP TECHNICAL COMMITTEE (TC) OFFICE BEARERS

PROPOSED DOCUMENT. Playbook for Implementation of a Medical Device Regulatory Framework. Authoring Group: AHWP TECHNICAL COMMITTEE (TC) OFFICE BEARERS AHWPTC/OB/P001:2014 PROPOSED DOCUMENT Title: Playbook for Implementation of a Medical Device Regulatory Framework Authoring Group: AHWP TECHNICAL COMMITTEE (TC) OFFICE BEARERS Date: August 5 th, 2014 This

More information

IMP Management and Accountability

IMP Management and Accountability This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document

More information

Corporate Presentation & Offer for SAP ATTP December 2015

Corporate Presentation & Offer for SAP ATTP December 2015 Corporate Presentation & Offer for SAP ATTP December 2015 Page : 1 Page : 2 Content Our Vision Our Company Business Challenges SAP Advanced Track and Trace for Pharmaceuticals (ATTP) Our Offer Our Vision

More information

Tuesday, 21 October Jang Yong Choi

Tuesday, 21 October Jang Yong Choi Tuesday, 21 October 2014 Jang Yong Choi Contents Status of Medical Device Industry in Korea MFDS Organization and Responsibilities Medical Device Regulation Overview Medical Device Regulation Updates I.

More information

St. James s Hospital leading global innovation in healthcare - a hospital wide approach to adopting GS1 standards

St. James s Hospital leading global innovation in healthcare - a hospital wide approach to adopting GS1 standards Healthcare provider implementation St. James s Hospital leading global innovation in healthcare - a hospital wide approach to adopting GS1 standards St. James s Hospital continues to lead the way by establishing

More information

PHARMACOVIGILANCE. Q: What is pharmacovigilance?

PHARMACOVIGILANCE. Q: What is pharmacovigilance? September 2017 PHARMACOVIGILANCE As many as one out of three drugs on the U.S. market may have safety issues, according to a recent study published in the Journal of the American Medical Association. 1

More information

Guidance notes and Application Form for Pharmacy Forum NI Guidance Development Pharmacist

Guidance notes and Application Form for Pharmacy Forum NI Guidance Development Pharmacist Guidance notes and Application Form for Pharmacy Forum NI Guidance Development Pharmacist Introduction Pharmacy Forum NI is the professional leadership body for all pharmacists registered to practice in

More information

Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association

Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association Before the House Energy and Commerce Subcommittee on Health 21st Century Cures: Examining the Regulation of Laboratory

More information

Personalised Healthcare Solutions (PHCS) Excellence for your Biomarker-driven Strategies

Personalised Healthcare Solutions (PHCS) Excellence for your Biomarker-driven Strategies Personalised Healthcare Solutions (PHCS) Excellence for your Biomarker-driven Strategies The value of In Vitro Diagnostics The value of diagnostics as an integral part in the healthcare value chain Diagnostics

More information

GUIDELINES FOR ISSUING AND RETURNING BLOOD COMPONENTS AND BLOOD PRODUCTS WITHIN A FACILITY

GUIDELINES FOR ISSUING AND RETURNING BLOOD COMPONENTS AND BLOOD PRODUCTS WITHIN A FACILITY GUIDELINES FOR ISSUING AND RETURNING BLOOD COMPONENTS AND BLOOD PRODUCTS WITHIN A FACILITY 1. Policy Statement 1.1 A policy shall be in place to ensure traceability of all blood components and blood products

More information

STATE OF THE ASIA-PACIFIC PHARMACEUTICAL INDUSTRY 2013: EXECUTIVE SUMMARY

STATE OF THE ASIA-PACIFIC PHARMACEUTICAL INDUSTRY 2013: EXECUTIVE SUMMARY STATE OF THE ASIA-PACIFIC PHARMACEUTICAL INDUSTRY 2013: EXECUTIVE SUMMARY State of the Asia-Pacific Pharmaceutical Industry The pharmaceutical industry in the Asia-Pacific region has recently been besieged

More information

Asia Pacific Economies Drive Quality

Asia Pacific Economies Drive Quality Asia Pacific Economies Drive Quality Industry s Response Jerry A Holmberg, Ph.D. Director, Scientific Business Development March 3, 2017 GRP No. DL/TMP/0217/0007 Agenda What is APEC? Why is blood sustainability

More information

2016 WHITE PAPER. Healthcare Supply Chain Imperatives

2016 WHITE PAPER. Healthcare Supply Chain Imperatives 2016 WHITE PAPER Healthcare Supply Chain Imperatives The healthcare industry is rapidly transforming through consolidation from relatively small provider organizations into large provider systems which

More information

Software Regulation: The Transfusion Medicine Experience

Software Regulation: The Transfusion Medicine Experience AMIA Invitational Policy Meeting September 9-10, 2009 Software Regulation: The Transfusion Medicine Experience Rodeina Davis Vice President & CIO Milwaukee, WI Founded 60 Years Ago, BloodCenter of Wisconsin

More information

Project responsibilities

Project responsibilities Project responsibilities Tallinn November 24th, 2017 Our Mission Falsified / counterfeit medicines are a serious risk for the citizens all around the world New legislation published on the 9th February

More information

An overview of the Asia Pacific Blood Network and Overview of the status of plasma fractionation in the region

An overview of the Asia Pacific Blood Network and Overview of the status of plasma fractionation in the region An overview of the Asia Pacific Blood Network and Overview of the status of plasma fractionation in the region Overview» APBN Membership Vision and mission & strategic objectives Activities Plasma for

More information

Unique Device Identifier (UDI) Labeling

Unique Device Identifier (UDI) Labeling INFORMATION SHEET Unique Device Identifier (UDI) Labeling On September 24, 2013, the United States Food and Drug Administration (FDA) released a final rule requiring that most medical devices distributed

More information

MARKETS & CUSTOMERS. Progressing globalization. Evolving markets

MARKETS & CUSTOMERS. Progressing globalization. Evolving markets Peptides are used worldwide in medical research. They contribute immensely to the understanding of diseases and have proven to be effective in medicinal products. Today, peptides can be produced at low

More information

Blood Traceability System for Indonesian Blood Supply Chain

Blood Traceability System for Indonesian Blood Supply Chain Proceeding of Industrial Engineering and Service Science,2015 Blood Traceability System for Indonesian Blood Supply Chain Iwan Vanany 1, Anny Maryani 1, Bilqis Amaliah 2, Ferrizal Rinaldy 1 and Fadel Muhammad

More information

Unique Device Identification (UDI): What is happening in Korea?

Unique Device Identification (UDI): What is happening in Korea? Healthcare Market Access Unique Device Identification (UDI): What is happening in Korea? May 11, 2017 Young Kim Synex Consulting Ltd. Objectives The Ministry of Food & Drug Safety (MFDS) plans to introduce

More information

Serialization a global approach. Emanuele Tellaroli Key Account Manager ANTARES VISION

Serialization a global approach. Emanuele Tellaroli Key Account Manager ANTARES VISION Serialization a global approach Emanuele Tellaroli Key Account Manager ANTARES VISION Beirut 02 June 2016 Serialization concept THE SMALLEST ITEM PUT ON SALE (selling unit) IS IDENTIFIED BY THE COMBINATION

More information

PMDA Update. - New Regulation in Japan and Future Direction of PMDA

PMDA Update. - New Regulation in Japan and Future Direction of PMDA PMDA Update - New Regulation in Japan and Future Direction of PMDA Kazuhiro SHIGETO, M.D., M.P.H., Ph.D. Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA) 1 Disclaimer The views and

More information

Draft Guidance for Industry Development and Use of Risk Minimization Action Plans

Draft Guidance for Industry Development and Use of Risk Minimization Action Plans Draft Guidance for Industry Development and Use of Risk Minimization Action Plans Docket Number [2004D-0188] Submitted to the U.S. Department of Health and Human Services Food and Drug Administration Center

More information

Overview and Life Cycle Planning for Biosimilars

Overview and Life Cycle Planning for Biosimilars September 23, 2011 The Biosimilars i il Competition and Innovation Act: Overview and Life Cycle Planning for Biosimilars Stephen Paul Mahinka Chair, Life Sciences & Healthcare Interdisciplinary Group smahinka@morganlewis.com

More information

Overview of the Drug Supply Chain Security Act. GPhA Fall Technical Conference Bethesda, MD October 28, 2014

Overview of the Drug Supply Chain Security Act. GPhA Fall Technical Conference Bethesda, MD October 28, 2014 Overview of the Drug Supply Chain Security Act GPhA Fall Technical Conference Bethesda, MD October 28, 2014 Disclaimer This presentation contains a summary of the opinion and perspective from GPhA member

More information

COUNTRY OVERVIEW: THAILAND. August 2012 SPECIAL REPRINT. By Rarana Phanudulkitti

COUNTRY OVERVIEW: THAILAND. August 2012 SPECIAL REPRINT. By Rarana Phanudulkitti August 2012 SPECIAL REPRINT COUNTRY OVERVIEW: THAILAND By Rarana Phanudulkitti Reproduced with the kind permission of Global Regulatory Press from the Journal of Medical Device Regulation, 2012, 9(3),

More information

Agreements on unique coding medical devices ADC

Agreements on unique coding medical devices ADC Agreements on unique coding medical devices ADC Final version 20 June 2017 2 Inhoud Management summary 6 1 Agreements concerning the introduction of unique coding for medical devices and drugs 8 1.1 Background

More information

I need a medicine while

I need a medicine while Meeting the global challenge of unique identification of medicinal products I need a medicine while abroad Contact: Anna.Gawronska-Blaszczyk@ilim.poznan.pl www.open-medicine.eu is a project funded by the

More information